Knowing When to Call It Quits in Drug Development and Healthcare Innovations

In this episode of BDO’s Health & Life Sciences Rx Podcast, BDO’s Howard Levine sits down with leaders from the Allen Institute for Brain Science, Comet Therapeutics, and McDermott Will & Emery to discuss how life sciences leaders can evaluate whether to continue pursuing a drug development program or cancel it.

Om Podcasten

BDO’s Health & Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence & Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.